Clinical Trials Directory

Heparin and Catheter-related Thrombosis in Neonates and Infants Following Cardiac Surgery

Heparin is frequently used in central venous catheters (CVCs) in post-operative cardiac patients. It remains unclear if a heparin infusion, compared to a normal saline infusion, prevents thrombosis of CVCs after surgery. This study will answer the question: does a low-dose heparin infusion (10 units/kg/h) prevent thrombosis, compared to a normal saline infusion, in patients less than one year of age after cardiac surgery?

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • drug : Placebo infusion
  • drug : Heparin sulfate infusion at 10 units/kg/hour

Phase: N/A


Ages Eligible For Study:

N/A - 1 Year

Inclusion Criteria

- All infants < 1 year of age undergoing cardiac surgery at Lucile Packard Children's Hospital & #xA

External Links

Explore related trials

Contact information

Primary Contact:

David Axelrod 4156072463

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: